U.S. flag

An official website of the United States government

NM_002905.5(RDH5):c.521del (p.Gly174fs) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 18, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003055647.3

Allele description [Variation Report for NM_002905.5(RDH5):c.521del (p.Gly174fs)]

NM_002905.5(RDH5):c.521del (p.Gly174fs)

Genes:
BLOC1S1-RDH5:BLOC1S1-RDH5 readthrough [Gene]
RDH5:retinol dehydrogenase 5 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
12q13.2
Genomic location:
Preferred name:
NM_002905.5(RDH5):c.521del (p.Gly174fs)
HGVS:
  • NC_000012.12:g.55721899del
  • NG_008606.1:g.6533del
  • NM_001199771.3:c.521del
  • NM_002905.5:c.521delMANE SELECT
  • NP_001186700.1:p.Gly174fs
  • NP_002896.2:p.Gly174fs
  • NC_000012.11:g.56115679del
  • NC_000012.11:g.56115683del
  • NR_037658.1:n.580del
Protein change:
G174fs
Molecular consequence:
  • NM_001199771.3:c.521del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_002905.5:c.521del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_037658.1:n.580del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003351500Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Apr 18, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Biochemical defects in 11-cis-retinol dehydrogenase mutants associated with fundus albipunctatus.

Lidén M, Romert A, Tryggvason K, Persson B, Eriksson U.

J Biol Chem. 2001 Dec 28;276(52):49251-7. Epub 2001 Oct 23.

PubMed [citation]
PMID:
11675386

Fundus albipunctatus: novel mutations and phenotypic description of Israeli patients.

Pras E, Pras E, Reznik-Wolf H, Sharon D, Raivech S, Barkana Y, Abu-Horowitz A, Ygal R, Banin E.

Mol Vis. 2012;18:1712-8. Epub 2012 Jun 23.

PubMed [citation]
PMID:
22815624
PMCID:
PMC3399783
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003351500.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Gly174Alafs*16) in the RDH5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RDH5 are known to be pathogenic (PMID: 11675386, 22815624). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RDH5-related conditions. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024